GlassScriptPhysician profile
Dipi Sharma
NPI 1841451135
$725.62
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $171 · 2021: $16.24 · 2022: $97.70.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $184.82 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $65.22 | 2022 | |
| Insmed, INC. | $48.72 | 2021-2022 | |
| Amgen INC. | $43.04 | 2020 | |
| Astellas Pharma US INC | $34.26 | 2019-2020 | |
| Travere Therapeutics, INC. | $31.65 | 2019-2020 | |
| Opko Pharmaceuticals, LLC | $30.48 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.83 | 2019 | |
| Philips North America LLC | $28.29 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $25.13 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $25.00 | 2020 | |
| Daiichi Sankyo INC. | $20.79 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.76 | 2019 | |
| Octapharma USA, INC. | $19.91 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.36 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $18.31 | 2019 | |
| T2 Biosystems, INC. | $17.81 | 2019 | |
| Shire North American Group INC | $14.78 | 2019 | |
| Mayne Pharma Commercial LLC | $14.29 | 2019 | |
| Genzyme Corporation | $12.67 | 2019 | |
| Gilead Sciences, INC. | $11.33 | 2019 | |
| Vifor Pharma, INC. | $11.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipi Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.